Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabetes Drug Discovery: hIAPP1-37 Polymorphic Amyloid Structures as Novel Therapeutic Targets.
Fernández-Gómez I, Sablón-Carrazana M, Bencomo-Martínez A, Domínguez G, Lara-Martínez R, Altamirano-Bustamante NF, Jiménez-García LF, Pasten-Hidalgo K, Castillo-Rodríguez RA, Altamirano P, Marrero SR, Revilla-Monsalve C, Valdés-Sosa P, Salamanca-Gómez F, Garrido-Magaña E, Rodríguez-Tanty C, Altamirano-Bustamante MM. Fernández-Gómez I, et al. Among authors: dominguez g. Molecules. 2018 Mar 19;23(3):686. doi: 10.3390/molecules23030686. Molecules. 2018. PMID: 29562662 Free PMC article.
Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures.
Sablón-Carrazana M, Fernández I, Bencomo A, Lara-Martínez R, Rivera-Marrero S, Domínguez G, Pérez-Perera R, Jiménez-García LF, Altamirano-Bustamante NF, Diaz-Delgado M, Vedrenne F, Rivillas-Acevedo L, Pasten-Hidalgo K, Segura-Valdez Mde L, Islas-Andrade S, Garrido-Magaña E, Perera-Pintado A, Prats-Capote A, Rodríguez-Tanty C, Altamirano-Bustamante MM. Sablón-Carrazana M, et al. Among authors: dominguez g. PLoS One. 2015 Sep 1;10(9):e0135292. doi: 10.1371/journal.pone.0135292. eCollection 2015. PLoS One. 2015. PMID: 26327208 Free PMC article.
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.
Candelaria M, de la Cruz-Hernandez E, Taja-Chayeb L, Perez-Cardenas E, Trejo-Becerril C, Gonzalez-Fierro A, Chavez-Blanco A, Soto-Reyes E, Dominguez G, Trujillo JE, Diaz-Chavez J, Duenas-Gonzalez A. Candelaria M, et al. Among authors: dominguez g. PLoS One. 2012;7(3):e29181. doi: 10.1371/journal.pone.0029181. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22427797 Free PMC article.
Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.
Chávez-Blanco A, De la Cruz-Hernández E, Domínguez GI, Rodríguez-Cortez O, Alatorre B, Pérez-Cárdenas E, Chacón-Salinas R, Trejo-Becerril C, Taja-Chayeb L, Trujillo JE, Contreras-Paredes A, Dueñas-González A. Chávez-Blanco A, et al. Among authors: dominguez gi. Int J Oncol. 2011 Dec;39(6):1491-9. doi: 10.3892/ijo.2011.1144. Epub 2011 Jul 26. Int J Oncol. 2011. PMID: 21805029
Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.
De la Cruz-Hernández E, Perez-Plasencia C, Pérez-Cardenas E, Gonzalez-Fierro A, Trejo-Becerril C, Chávez-Blanco A, Taja-Chayeb L, Vidal S, Gutiérrez O, Dominguez GI, Trujillo JE, Duenas-González A. De la Cruz-Hernández E, et al. Oncol Rep. 2011 Feb;25(2):399-407. doi: 10.3892/or.2010.1086. Epub 2010 Dec 8. Oncol Rep. 2011. PMID: 21152880
390 results